Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
New discovery rarely runs smooth: an update on progranulin/TNFR interactions.
Neural progenitor cells isolated from the subventricular zone present hemichannel activity and form functional gap junctions with glial cells.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management.
Cost-Effectiveness of Dimethyl Fumarate Treatment for Relapsing-Remitting Multiple Sclerosis From A Danish Perspective.
Effect Of Fingolimod On Disease Progressions, Relapse Rate And Brain Atrophy In Multiple Sclerosis Patients: Review Of Literature And Pharmacoeconomic Considerations.
Visual field characteristics in neuromyelitis optica in absence of and after one episode of optic neuritis.
Efficacy of subcutaneous interferon β-1a on MRI outcomes in a randomised controlled trial of patients with clinically isolated syndromes.
Delayed Liver Function Impairment Secondary to Interferon β-1a Use in Multiple Sclerosis.
Assessing humoral immunocompetence after alemtuzumab treatment in MS.
Diagnostic data for neurological conditions in interRAI assessments in home care, nursing home and mental health care settings: a validity study.
[Multiple sclerosis within the Spanish context].
Three decades of drift: the misdiagnosis of predominantly neuropsychiatric multiple sclerosis.
Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast.
"Nine" syndrome: A new neuro-ophthalmologic syndrome: Report of two cases.
Preliminary study on patients located at the Kashani/Isfahan Hospital with multiple sclerosis between the years 2011 and 2013.
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
Cancer specific risk in multiple sclerosis patients.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
Central motor conduction as a measure of disease progression in early multiple sclerosis.
Effect of axotomy and 17β-estradiol on P2X7 receptor expression pattern in the hypoglossal nucleus of ovariectomized mice.
Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Alemtuzumab for multiple sclerosis.
Effect of 10-day forced treadmill training on neurotrophic factors in experimental autoimmune encephalomyelitis.
Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions.
Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy.
Pages
« first
‹ previous
…
675
676
677
678
679
680
681
682
683
…
next ›
last »